Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

Saved in:
Bibliographic Details
Published inDigestive diseases and sciences Vol. 66; no. 6; pp. 2129 - 2134
Main Authors Hayashi, Yukie, Hosoe, Naoki, Takabayashi, Kaoru, Limpias Kamiya, Kenji J. L., Tsugaru, Kai, Shimozaki, Keitaro, Hirata, Kenro, Fukuhara, Kayoko, Fukuhara, Seiichiro, Mutaguchi, Makoto, Sujino, Tomohisa, Sukawa, Yasutaka, Hamamoto, Yasuo, Naganuma, Makoto, Takaishi, Hiromasa, Shimoda, Masayuki, Ogata, Haruhiko, Kanai, Takanori
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2021
Springer
Springer Nature B.V
Subjects
Aged
Apoptosis
Biochemistry
Case Report
Colitis - chemically induced
Colitis - diagnosis
Colon
Colonoscopy
Comorbidity
Diarrhea
Endoscopy
Endoscopy, Gastrointestinal - methods
Female
Gastritis - chemically induced
Gastritis - diagnosis
Gastroenteritis - chemically induced
Gastroenteritis - diagnosis
Gastroenterology
Health aspects
Hepatology
Hospitals
Humans
Immune Checkpoint Inhibitors - adverse effects
Inflammation
Inflammatory bowel disease
Ipilimumab
Male
Medical colleges
Medical prognosis
Medicine
Medicine & Public Health
Middle Aged
Monoclonal antibodies
Oncology
Pain
Patients
Proteins
Rectum
Remission (Medicine)
Retrospective Studies
Transplant Surgery
Immune check point inhibitor
Enteritis
Immune-rerated adverse events (irAE)
Colitis
Gastritis
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-020-06441-w